Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia.

MLA

Peffault de Latour, Régis, et al. “Nationwide Survey on the Use of Horse Antithymocyte Globulins (ATGAM) in Patients with Acquired Aplastic Anemia: A Report on Behalf of the French Reference Center for Aplastic Anemia.” American Journal of Hematology, vol. 93, no. 5, May 2018, pp. 635–42. EBSCOhost, https://doi.org/10.1002/ajh.25050.

APA

Peffault de Latour, R., Tabrizi, R., Marcais, A., Leblanc, T., Lamy, T., Mohty, M., Tavitian, S., Jubert, C., Pasquet, M., Galambrun, C., Nguyen, S., Cahn, J. Y., Braun, T., Deconinck, E., Bay, J. O., Sicre de Fontbrune, F., Barraco, F., & Socié, G. (2018). Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia. American Journal of Hematology, 93(5), 635–642. https://doi.org/10.1002/ajh.25050

Chicago

Peffault de Latour, Régis, Reza Tabrizi, Ambroise Marcais, Thierry Leblanc, Thierry Lamy, Mohamad Mohty, Suzanne Tavitian, et al. 2018. “Nationwide Survey on the Use of Horse Antithymocyte Globulins (ATGAM) in Patients with Acquired Aplastic Anemia: A Report on Behalf of the French Reference Center for Aplastic Anemia.” American Journal of Hematology 93 (5): 635–42. doi:10.1002/ajh.25050.